Acurx Pharmaceuticals, Inc.
ACXP
$1.43
$0.00-0.07%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.51M | -7.50M | -7.97M | -9.17M | -10.00M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.32M | 1.45M | 1.57M | 1.73M | 1.86M |
| Change in Net Operating Assets | 6.60K | -90.80K | -391.00K | -415.70K | -22.50K |
| Cash from Operations | -6.18M | -6.14M | -6.79M | -7.85M | -8.16M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10.92M | 10.93M | 10.78M | 8.00M | 7.87M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -146.00K | -174.80K | -146.00K | -1.00K | -- |
| Cash from Financing | 10.78M | 10.75M | 10.64M | 8.00M | 7.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.59M | 4.61M | 3.85M | 144.20K | -296.80K |